Medical comorbidities predict mortality in women with a history of early stage breast cancer.
about
Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities.The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL StudyImpact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of ChinaClinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer.Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohortObesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort StudyMultimorbidity: an issue of growing importance for oncologistsConstruction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia.Lifestyle interventions for cardiovascular risk reduction in women with breast cancer.Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC)The impact of diabetes mellitus on prognosis of early breast cancer in Asia.Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.Diabetes and breast cancer mortality in Black women.Barriers and facilitators to recruitment to a culturally-based dietary intervention among urban Hispanic breast cancer survivors.Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE studyCardiovascular Disease Mortality Among Breast Cancer Survivors.Associations of soluble fiber, whole fruits/vegetables, and juice with plasma Beta-carotene concentrations in a free-living population of breast cancer survivorsBody mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened populationExercise as a prescription therapy for breast and colon cancer survivorsImpact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors.Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study.The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality.The impact of comorbidity on cancer survival: a reviewDiabetes, metformin, and breast cancer in postmenopausal womenBiomarkers of the metabolic syndrome and breast cancer prognosis.Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study.A review of cancer in U.S. Hispanic populations.Diet and breast cancer: understanding risks and benefits.Treatment and outcomes in diabetic breast cancer patients.Practical clinical interventions for diet, physical activity, and weight control in cancer survivors.Post-treatment problems of African American breast cancer survivors.Sleep duration and breast cancer prognosis: perspectives from the Women's Healthy Eating and Living Study.Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).Understanding the Association of Type 2 Diabetes Mellitus in Breast Cancer Among African American and European American Populations in South Carolina.Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study.Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin.Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the Spanish National Hospital Discharge Database, 2013-2014.
P2860
Q31171263-0C56C6B2-0788-424E-B634-BD5D63FD3BDDQ34090619-832FA28E-C9E1-4C2D-A190-48302919F9DEQ34609703-B2961BA0-4B28-47F0-BB68-6378F784F49EQ34662865-CCD10879-6C78-4D47-80F4-7F9DF4F68D40Q35014899-C7A2F1DA-18B0-4F5F-827A-0898ACB3D05FQ35187582-AEBBA265-C332-4199-800B-585EB92E2338Q35559778-BA56A508-37CB-4F14-8F01-7561E5CBEB16Q35593300-9FBB1659-6D4E-491F-BB5A-23A3DA98B47EQ35711979-29D9EEF1-27F2-4626-9D57-92231D0DE59FQ35745395-556EE871-302C-40F7-9672-8A2F57007BB8Q35878469-9ECDF721-8096-496A-AB69-FD8D63E48920Q35911581-4B75CB74-059C-4C5C-B1B1-9596E6F85258Q35913204-CF31F15B-7A26-4F5D-9DEB-379D71C45771Q35974499-FDFB272E-F6B7-4E05-A571-81C5701CFD07Q36229115-57181D62-EBA6-460F-AD2D-8354D6D6EC0CQ36256844-DB0D5301-CDFA-4E45-BF32-6CC7BB4C1321Q36315921-C78DF2B3-C4AF-4A36-BA25-C89C33606218Q36338451-A6D39CD7-B6EE-4386-B5DF-323A5E7D78EAQ36378734-3D308D2D-B053-44A3-9D07-045998DC7B93Q36569214-95399064-9754-4660-B3B4-5A46428FD9D3Q36787876-F11EE01A-46CB-4AC0-B217-AE98985A5BCFQ36899847-9E37C8B9-EC2A-4585-93F2-7FE3CADD89D9Q37017213-08843528-3777-4BAF-B41C-3DAF5277A281Q37059764-B6DEA3F4-94A6-48D5-A113-C0CCD4389BF7Q37288186-93C6EFDA-DA14-47BD-8D57-49DE7A307468Q37303867-376714D6-5727-4BD7-9E09-DAABF887B888Q37328339-BAB851F8-09D9-4C2A-9557-97B5B168EDCEQ37381031-677C2655-1544-4368-9557-A7FF2B6436F0Q37981608-25363ADF-8F00-4E9A-9965-28E3F0379D64Q38040690-50E71A8D-EAAA-467F-9B4B-B9A75ECCB43FQ38180008-E70F81F8-5086-45ED-A891-5B1BB09FDC16Q38356424-C9D2DDB0-7E71-419D-BF14-3D0B6E860C61Q38804952-D399EC96-67F5-479C-BD9F-63A3B5124778Q38965221-955A6C9E-BBFE-4EB1-87CC-EAA5244EDFF3Q39946079-C601BBDE-27F3-4FF6-9D49-D05814A0807EQ40075923-66F6E2A4-6D6C-4629-9CEB-2974346CCB44Q40704869-FBAF776F-B8D9-4400-B9F0-709D83B8260FQ40781176-8A3CDFD7-F90E-4D6B-97F7-C0776932931EQ44459340-5EC9C7B3-3023-48A3-B972-D70DA0BAFF3CQ47619617-A8E63504-585F-4792-82DE-996CC7BB3ED3
P2860
Medical comorbidities predict mortality in women with a history of early stage breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Medical comorbidities predict ...... of early stage breast cancer.
@ast
Medical comorbidities predict ...... of early stage breast cancer.
@en
type
label
Medical comorbidities predict ...... of early stage breast cancer.
@ast
Medical comorbidities predict ...... of early stage breast cancer.
@en
prefLabel
Medical comorbidities predict ...... of early stage breast cancer.
@ast
Medical comorbidities predict ...... of early stage breast cancer.
@en
P2093
P2860
P1476
Medical comorbidities predict ...... of early stage breast cancer.
@en
P2093
Barbara A Parker
Cheryl L Rock
Cynthia A Thomson
Gail A Laughlin
John P Pierce
Kirsten Erickson
Nazmus Saquib
Richard A Hajek
Ruth E Patterson
Shirley W Flatt
P2860
P2888
P304
P356
10.1007/S10549-010-0732-3
P407
P50
P577
2010-01-14T00:00:00Z
P5875
P6179
1006994064